Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Filings indexed 1,608 across all filing types
Latest filing 2022-03-09 Director's Dealing
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
111年02月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings of insiders, including directors, supervisors, and executives, with specific numbers of shares held, pledged shares, and related percentages. It is focused on insider shareholdings and their changes or status. There is no indication of financial results, earnings, management discussion, or other report types. The document is not a report itself but a disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is under 5,000 characters and contains detailed insider shareholding data, confirming it is a Director's Dealing report rather than a general regulatory filing or announcement.
2022-03-09 Chinese
本公司董事會決議辦理私募發行國內可轉換公司債 (包括有擔保或無擔保可轉換公司債)
Capital/Financing Update Classification · 95% confidence The document is a company announcement regarding a board resolution to issue domestic convertible bonds (including secured or unsecured convertible bonds) through private placement. It details the issuance plan, authorization requests to the shareholders' meeting, and related terms such as issuance amount, price, period, and use of proceeds. There is no financial statement or comprehensive financial report included. The document is an update on capital raising activities and financing plans rather than a full financial report or earnings release. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is short (1507 characters), but it contains substantive information about financing decisions, not just a report publication announcement or a regulatory filing. Hence, the classification is CAP with high confidence.
2022-03-08 Chinese
本公司董事會決議辦理私募發行普通股
Capital/Financing Update Classification · 100% confidence The document is a regulatory announcement from a listed company (1762 中化生) regarding a board resolution to conduct a private placement of common shares and convertible bonds. It details the terms, pricing basis, authorization requests, and strategic rationale for the private placement. The content focuses on capital raising activities, including issuance of new shares and convertible bonds, and the authorization for the board to execute the plan. There are no financial statements or comprehensive financial data presented, nor is this a report or presentation. The document is an update on capital/financing activities, specifically a private placement issuance plan. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is short and it is not merely an announcement of a report publication, so it is not RPA or RNS.
2022-03-08 Chinese
董事會決議股利分派
Notice of Dividend Amount Classification · 95% confidence The document is a short announcement (764 characters) from a company (1762 中化生) regarding a board resolution on dividend distribution. It specifies dividend amounts, the fiscal year (110年年度), and related details. There is no detailed financial report or analysis, only the dividend decision. The document is not a full annual or interim report, nor a proxy or AGM material. It fits the definition of a Notice of Dividend Amount (DIV) as it announces dividend amounts and payment details to shareholders.
2022-03-08 Chinese
公告本公司董事會通過110年度合併財務報告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a listed company (1762 中化生) reporting the board's approval of the consolidated financial report for the fiscal year 110 (which corresponds to 2021). It includes cumulative financial figures for the full year (from 110/01/01 to 110/12/31) such as revenue, gross profit, operating profit, net profit before tax, net profit, net profit attributable to parent company owners, earnings per share, total assets, total liabilities, and equity attributable to parent company owners. The document is relatively short (907 characters) and appears to be a formal announcement of the board's approval of the annual consolidated financial report rather than the full annual report itself. There is no detailed financial statement or extensive analysis present, just summarized financial data and approval dates. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an official announcement of the board's approval of the annual financial report, not the full Annual Report (10-K) itself.
2022-03-08 Chinese
公告本公司董事會決議召開111年股東常會相關事宜 (新增討論事項)
AGM Information Classification · 95% confidence The document is a public announcement from a listed company (1762 中化生) regarding the board of directors' resolution to convene the 111th Annual General Meeting (AGM). It details the date, location, and agenda items for the AGM, including reports, approvals, discussions, elections, and other matters. The document is short (1030 characters) and serves as a notice about the AGM arrangements rather than the AGM materials or minutes themselves. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related announcements about the AGM.
2022-03-08 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.